← Braidwell portfolio
13F-HR filing
VALIDATEDHoldings period 2024-09-30 · Filed 2024-11-14 · Accession 0001920938-24-000006
Open official SEC source ↗| # | Issuer | Class / CUSIP | Kind | Shares | Value |
|---|---|---|---|---|---|
| 1 | 4D MOLECULAR THERAPEUTICS IN | COM · 35104E100 | LONG | 1,225,448 | $13.2 million |
| 2 | ALECTOR INC | COM · 014442107 | LONG | 2,158,245 | $10.1 million |
| 3 | ALIGN TECHNOLOGY INC | COM · 016255101 | LONG | 311,679 | $79.3 million |
| 4 | ALPHATEC HLDGS INC | COM NEW · 02081G201 | LONG | 4,041,065 | $22.5 million |
| 5 | ALPHATEC HLDGS INC | NOTE 0.750% 8/0 · 02081GAB8 | LONG | 58,217,000 | $52.5 million |
| 6 | AMPHASTAR PHARMACEUTICALS IN | NOTE 2.000% 3/1 · 03209RAB9 | LONG | 18,400,000 | $19.5 million |
| 7 | APELLIS PHARMACEUTICALS INC | COM · 03753U106 | LONG | 3,125,183 | $90.1 million |
| 8 | APOGEE THERAPEUTICS INC | COM · 03770N101 | LONG | 1,643,226 | $96.5 million |
| 9 | ARGENX SE | SPONSORED ADR · 04016X101 | LONG | 96,724 | $52.4 million |
| 10 | ARVINAS INC | COM · 04335A105 | LONG | 1,284,472 | $31.6 million |
| 11 | AVADEL PHARMACEUTICALS PLC | COM SHS · G29687103 | LONG | 3,388,939 | $44.4 million |
| 12 | BICARA THERAPEUTICS INC | COM · 055477103 | LONG | 1,657,600 | $42.2 million |
| 13 | BIONTECH SE | SPONSORED ADS · 09075V102 | LONG | 247,750 | $29.4 million |
| 14 | BOSTON SCIENTIFIC CORP | COM · 101137107 | LONG | 189,200 | $15.9 million |
| 15 | BRIDGEBIO PHARMA INC | COM · 10806X102 | LONG | 298,400 | $7.6 million |
| 16 | BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 · 10806XAD4 | LONG | 53,594,000 | $45.0 million |
| 17 | BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 · 10806XAB8 | LONG | 140,838,000 | $145.6 million |
| 18 | CASTLE BIOSCIENCES INC | COM · 14843C105 | LONG | 331,986 | $9.5 million |
| 19 | CELCUITY INC | COM · 15102K100 | LONG | 884,306 | $13.2 million |
| 20 | CG ONCOLOGY INC | COM · 156944100 | LONG | 3,170,875 | $119.6 million |
| 21 | CULLINAN THERAPEUTICS INC | COM · 230031106 | LONG | 1,176,173 | $19.7 million |
| 22 | CUTERA INC | NOTE 4.000% 6/0 · 232109AG3 | LONG | 29,000,000 | $5.0 million |
| 23 | CUTERA INC | NOTE 2.250% 6/0 · 232109AD0 | LONG | 25,240,000 | $4.0 million |
| 24 | DAY ONE BIOPHARMACEUTICALS I | COM · 23954D109 | LONG | 4,873,853 | $67.9 million |
| 25 | DBV TECHNOLOGIES S A | SPONSORED ADR · 23306J200 | LONG | 1,630,542 | $1.1 million |
| 26 | DEXCOM INC | COM · 252131107 | LONG | 441,086 | $29.6 million |
| 27 | DEXCOM INC | NOTE 0.375% 5/1 · 252131AM9 | LONG | 92,700,000 | $82.3 million |
| 28 | DEXCOM INC | NOTE 0.250%11/1 · 252131AK3 | LONG | 73,500,000 | $70.1 million |
| 29 | DIANTHUS THERAPEUTICS INC | COM · 252828108 | LONG | 493,687 | $13.5 million |
| 30 | EDGEWISE THERAPEUTICS INC | COM · 28036F105 | LONG | 1,958,310 | $52.3 million |
| 31 | ELEVATION ONCOLOGY INC | COM · 28623U101 | LONG | 473,503 | $284,054 |
| 32 | EXACT SCIENCES CORP | COM · 30063P105 | LONG | 286,178 | $19.5 million |
| 33 | FULCRUM THERAPEUTICS INC | COM · 359616109 | LONG | 1,069,158 | $3.8 million |
| 34 | GLAUKOS CORP | COM · 377322102 | LONG | 311,616 | $40.6 million |
| 35 | GUARDANT HEALTH INC | COM · 40131M109 | LONG | 3,342,124 | $76.7 million |
| 36 | GUARDANT HEALTH INC | NOTE11/1 · 40131MAB5 | LONG | 268,252,000 | $216.0 million |
| 37 | HAEMONETICS CORP MASS | NOTE3/0 · 405024AB6 | LONG | 11,500,000 | $10.6 million |
| 38 | HARROW INC | COM · 415858109 | LONG | 439,638 | $19.8 million |
| 39 | HILLEVAX INC | COM · 43157M102 | LONG | 1,064,000 | $1.9 million |
| 40 | IMMATICS N.V | SHS · N44445109 | LONG | 1,647,565 | $18.8 million |
| 41 | INSPIRE MED SYS INC | COM · 457730109 | LONG | 238,911 | $50.4 million |
| 42 | INSULET CORP | COM · 45784P101 | LONG | 42,500 | $9.9 million |
| 43 | INSULET CORP | NOTE 0.375% 9/0 · 45784PAK7 | LONG | 63,800,000 | $76.4 million |
| 44 | INTUITIVE SURGICAL INC | COM NEW · 46120E602 | LONG | 91,300 | $44.9 million |
| 45 | IOVANCE BIOTHERAPEUTICS INC | COM · 462260100 | LONG | 217,928 | $2.0 million |
| 46 | IRHYTHM HOLDINGS INC | COM · 450056106 | LONG | 782,557 | $58.1 million |
| 47 | IRONWOOD PHARMACEUTICALS INC | COM CL A · 46333X108 | LONG | 4,438,232 | $18.3 million |
| 48 | IRONWOOD PHARMACEUTICALS INC | NOTE 1.500% 6/1 · 46333XAH1 | LONG | 92,740,000 | $82.5 million |
| 49 | JASPER THERAPEUTICS INC | COM NEW · 471871202 | LONG | 483,300 | $9.1 million |
| 50 | KEROS THERAPEUTICS INC | COM · 492327101 | LONG | 707,240 | $41.1 million |
| 51 | KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A · G52694109 | LONG | 2,894,513 | $72.3 million |
| 52 | KRYSTAL BIOTECH INC | COM · 501147102 | LONG | 168,691 | $30.7 million |
| 53 | LEGEND BIOTECH CORP | SPONSORED ADS · 52490G102 | LONG | 1,541,551 | $75.1 million |
| 54 | LEXEO THERAPEUTICS INC | COM · 52886X107 | LONG | 728,777 | $6.6 million |
| 55 | LEXICON PHARMACEUTICALS INC | COM NEW · 528872302 | LONG | 801,584 | $1.3 million |
| 56 | MADRIGAL PHARMACEUTICALS INC | COM · 558868105 | LONG | 183,818 | $39.0 million |
| 57 | MARAVAI LIFESCIENCES HLDGS I | COM CL A · 56600D107 | LONG | 8,353,287 | $69.4 million |
| 58 | NEOGENOMICS INC | NOTE 0.250% 1/1 · 64049MAB6 | LONG | 116,381,000 | $96.9 million |
| 59 | NEUROCRINE BIOSCIENCES INC | COM · 64125C109 | LONG | 917,674 | $105.7 million |
| 60 | NEVRO CORP | COM · 64157F103 | LONG | 1,698,768 | $9.5 million |
| 61 | NOVOCURE LTD | NOTE11/0 · 67011XAB9 | LONG | 140,834,000 | $133.3 million |
| 62 | NUVASIVE INC | NOTE 0.375% 3/1 · 670704AJ4 | LONG | 114,206,000 | $111.9 million |
| 63 | OCULAR THERAPEUTIX INC | COM · 67576A100 | LONG | 2,239,770 | $19.5 million |
| 64 | ORTHOPEDIATRICS CORP | COM · 68752L100 | LONG | 1,107,770 | $30.0 million |
| 65 | ORUKA THERAPEUTICS INC | COM · 687604108 | LONG | 515,726 | $12.6 million |
| 66 | PARAGON 28 INC | COM · 69913P105 | LONG | 4,135,109 | $27.6 million |
| 67 | PENUMBRA INC | COM · 70975L107 | LONG | 361,428 | $70.2 million |
| 68 | PULMONX CORP | COM · 745848101 | LONG | 752,541 | $6.2 million |
| 69 | RELAY THERAPEUTICS INC | COM · 75943R102 | LONG | 3,499,427 | $24.8 million |
| 70 | REPLIGEN CORP | COM · 759916109 | LONG | 396,781 | $59.0 million |
| 71 | REPLIMUNE GROUP INC | COM · 76029N106 | LONG | 3,070,837 | $33.7 million |
| 72 | SAREPTA THERAPEUTICS INC | COM · 803607100 | LONG | 370,400 | $46.3 million |
| 73 | SPYRE THERAPEUTICS INC | COM NEW · 00773J202 | LONG | 2,189,836 | $64.4 million |
| 74 | THE BEAUTY HEALTH COMPANY | COM CL A · 88331L108 | LONG | 4,049,694 | $5.8 million |
| 75 | TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 · 761299AB2 | LONG | 56,031,000 | $53.5 million |
| 76 | VAXCYTE INC | COM · 92243G108 | LONG | 297,568 | $34.0 million |
| 77 | VERVE THERAPEUTICS INC | COM · 92539P101 | LONG | 623,980 | $3.0 million |
| 78 | VIKING THERAPEUTICS INC | COM · 92686J106 | LONG | 1,156,977 | $73.2 million |
| 79 | XENCOR INC | COM · 98401F105 | LONG | 466,448 | $9.4 million |
| 80 | XENON PHARMACEUTICALS INC | COM · 98420N105 | LONG | 2,707,255 | $106.6 million |
| 81 | ZURA BIO LTD | CLASS A ORD SHS · G9TY5A101 | LONG | 2,472,806 | $10.0 million |